Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-048003
Filing Date
2005-03-11
Accepted
2005-03-11 17:01:08
Documents
13
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 d10k.htm 10-K 1303471
2 SPECIMEN CERTIFICATE dex41.htm EX-4.1 17654
3 TERMINATION AGREEMENT: ERIC P. LOUKAS dex1033.htm EX-10.33 36137
4 TERMINATION AGREEMENT: MARTY J. DUVALL dex1039.htm EX-10.39 37317
5 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex12.htm EX-12 46683
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 3106
7 SECTION 302 CERTIFICATION dex311.htm EX-31.1 7932
8 SECTION 302 CERTIFICATION dex312.htm EX-31.2 7988
9 SECTION 906 CERTIFICATION dex321.htm EX-32.1 4036
10 SECTION 906 CERTIFICATION dex322.htm EX-32.2 4040
11 GRAPHIC g15619g58g26.jpg GRAPHIC 16985
12 GRAPHIC g15619g70v47.jpg GRAPHIC 15373
13 GRAPHIC g15619g89w96.jpg GRAPHIC 11425
  Complete submission text file 0001193125-05-048003.txt   1515350
Mailing Address 5775 WEST OLD SHAKOPEE RD SUITE 100 MINNEAPOLIS MN 55437
Business Address 5775 WEST OLD SHAKOPEE RD SUITE 100 BLOOMINGTON MN 55437 952-346-4700
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-10736 | Film No.: 05676147
SIC: 2834 Pharmaceutical Preparations